Summary Background Non-communicable diseases (NCDs) are increasing among people
living with HIV (PLHIV), especially in Sub-Saharan Africa (SSA). We determined the …

As longevity has increased for people living with HIV (PLWH) in the United States and
Europe, there has been a concomitant increase in the prevalence of cardiovascular disease …

Background Data on the burden of dyslipidaemia among people with HIV undergoing
antiretroviral therapy (ART) in sub-Saharan Africa are limited and little is known about the …

Background HIV and antiretroviral drugs, particularly protease inhibitors and nucleoside
reverse transcriptase inhibitors, may increase the risk of Metabolic Syndrome (MetS) among …

Background. There is an increasing prevalence of cardiovascular diseases (CVDs) and risk
factors in HIV patients as the levels of AIDS‐related mortality and morbidity decrease …

Introduction This article aimed to compare the prevalence of dyslipidemia and determine risk
factors associated with lipid levels in a cohort of HIV-infected patients receiving two different …

Background: While the fast extension of combination antiretroviral therapy (cART) has
resulted in significant increases in life expectancy, disorders such as cardiometabolic …

Background Inflammation drives vascular dysfunction in HIV, but in low-income settings
causes of inflammation are multiple, and include infectious and environmental factors. We …

Prevalence data on DM is vital for medical decisionmaking and the appropriate allocation of
healthcare resources. Nonetheless, very few studies have investigated DM prevalence …

Background The co-morbidity of cardiometabolic diseases in patients with Tuberculosis
adds a significant burden in current health systems in developing countries including Nepal …